Prestige Consumer Healthcare (PBH) Intangibles (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Intangibles of $2.3 billion for Q4 2025, little changed year-over-year from $2.3 billion in Q4 2024, and little changed quarter-over-quarter from $2.3 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Intangibles (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Intangibles history runs 15 years deep, the most recent figure standing at $2.3 billion for Q4 2025.
- In Q4 2025, Intangibles changed 0.39% year-over-year to $2.3 billion; the TTM figure through Dec 2025 stood at $2.3 billion (changed 0.39% YoY), while the FY2025 annual figure was $2.3 billion, down 1.09% from the prior year.
- Intangibles for Q4 2025 stood at $2.3 billion, roughly flat from $2.3 billion in the prior quarter.
- The five-year high for Intangibles was $2.7 billion in Q4 2021, with the low at $2.3 billion in Q3 2025.
- The 5-year median for Intangibles is $2.3 billion (2023), against an average of $2.4 billion.
- The sharpest annual moves came in 2021 and 2023: Intangibles increased 8.94% in 2021, then declined 13.15% in 2023.
- Prestige Consumer Healthcare's Intangibles stood at $2.7 billion in 2021, then decreased by 1.23% to $2.7 billion in 2022, then decreased by 12.8% to $2.3 billion in 2023, then fell by 0.77% to $2.3 billion in 2024, then slipped by 0.39% to $2.3 billion in 2025.
- Business Quant data shows PBH's Intangibles at $2.3 billion in Q4 2025, $2.3 billion in Q3 2025, and $2.3 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | 2.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Bn |
| Dec 31, 2025 | 2.30 Bn |
| Sep 30, 2025 | 2.29 Bn |
| Jun 30, 2025 | 2.29 Bn |
| Mar 31, 2025 | 2.30 Bn |
| Dec 31, 2024 | 2.31 Bn |
| Sep 30, 2024 | 2.32 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 2.32 Bn |
| Dec 31, 2023 | 2.33 Bn |
| Sep 30, 2023 | 2.33 Bn |
| Jun 30, 2023 | 2.34 Bn |
| Mar 31, 2023 | 2.34 Bn |
| Dec 31, 2022 | 2.67 Bn |
| Sep 30, 2022 | 2.67 Bn |
| Jun 30, 2022 | 2.68 Bn |
| Mar 31, 2022 | 2.70 Bn |
| Dec 31, 2021 | 2.70 Bn |
| Sep 30, 2021 | 2.69 Bn |
| Jun 30, 2021 | 2.47 Bn |